# All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve

Study · id `cardio:ct-nct05989074` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05989074](<https://clinicaltrials.gov/study/NCT05989074>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05989074

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

## Technical summary

Registry record NCT05989074. Randomized; single masking; primary purpose other. Start 2024-02-01 (anticipated); primary completion 2025-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose other
- Phase: Not applicable
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT05989074, source copy `cardio:ctgov-nct05989074-2024-01-12`, retrieved 2026-10-26)
- Planned start: 2024-02-01 (anticipated) (ClinicalTrials.gov record NCT05989074, source copy `cardio:ctgov-nct05989074-2024-01-12`, retrieved 2026-10-26)
- Primary completion: 2025-08-31 (anticipated) (ClinicalTrials.gov record NCT05989074, source copy `cardio:ctgov-nct05989074-2024-01-12`, retrieved 2026-10-26)
- Completion: 2025-08-31 (anticipated) (ClinicalTrials.gov record NCT05989074, source copy `cardio:ctgov-nct05989074-2024-01-12`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05989074-2024-01-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve
- Condition: Aortic Stenosis, Severe
- Intervention (Device): ALLEGRA TAVI System TF
- Intervention (Device): Ballon-expandable valve system
- Lead sponsor: Ceric Sàrl
- Lead sponsor class: INDUSTRY
- Collaborator: Biosensors International
- Collaborator class: OTHER
- Collaborator: European Cardiovascular Research Center
- Collaborator class: NETWORK

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Ceric Sàrl (`cardio:org-ceric-sarl`)
- Registry lists this organization as a collaborator: Biosensors International (`cardio:org-biosensors-international`)
- Registry lists this organization as a collaborator: European Cardiovascular Research Center (`cardio:org-european-cardiovascular-research-center`)

## Provenance

Content hash: 48641f47c788c51eac31f0981cb60bfa533281a3265432c2d519fd3f46bfc37a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
